United States · FDA National Drug Code directory
Lisdexamfetamine dimesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-134_a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811
- Product NDC
- 72205-134
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Lisdexamfetamine dimesylate
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240202
- Source listing expiry
- 20261231
Source-listed ingredients
- LISDEXAMFETAMINE DIMESYLATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, CHEWABLE in 1 BOTTLE (72205-134-91) · 72205-134-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →